Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
Asset disposition
Cert. of designation
Director departure
Appointed director
|
|
ALIMERA SCIENCES INC (ALIM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/03/2023 |
SC 13G/A
| Palo Alto Investors LP reports a 0% stake in Alimera Sciences, Inc. |
| 02/14/2023 |
SC 13G/A
| Palo Alto Investors LP reports a 11.4% stake in Alimera Sciences, Inc. |
| 02/08/2023 |
SC 13G/A
| MORGAN STANLEY reports a 9.5% stake in ALIMERA SCIENCES INC |
| 10/27/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/10/2022 |
SC 13G/A
| MORGAN STANLEY reports a 13.3% stake in ALIMERA SCIENCES INC |
| 02/14/2022 |
SC 13G/A
| Palo Alto Investors LP reports a 11.6% stake in Alimera Sciences, Inc. |
| 02/10/2022 |
SC 13G/A
| MORGAN STANLEY reports a 6.2% stake in ALIMERA SCIENCES INC |
| 02/03/2022 |
SC 13G/A
| HIRSCHMAN ORIN reports a 12% stake in Alimera Sciences, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Avoro Capital Advisors LLC reports a 0% stake in Alimera Sciences, Inc. |
| 02/10/2021 |
SC 13G/A
| HIRSCHMAN ORIN reports a 9.8% stake in Alimera Sciences, Inc. |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 4.6% stake in Alimera Sciences, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| HIRSCHMAN ORIN reports a 9.5% stake in Alimera Sciences, Inc. |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2020 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 9.4% stake in Alimera Sciences, Inc. |
| 02/11/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/23/2020 |
SC 13G/A
| Flynn James E reports a 10% stake in Alimera Sciences, Inc. |
| 02/14/2019 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 5% stake in ALIMERA SCIENCES, INC. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| venBio Select Advisor LLC reports a 8.9% stake in Alimera Sciences, Inc. |
| 02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 5.1% stake in ALIMERA SCIENCES, INC. |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 5.1% stake in Alimera Sciences, Inc. |
| 02/12/2018 |
SC 13G/A
| venBio Select Advisor LLC reports a 9% stake in Alimera Sciences, Inc. |
| 10/12/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|
|